SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-047568
Filing Date
2023-06-08
Accepted
2023-06-08 18:42:24
Documents
1
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3772
  Complete submission text file 0001213900-23-047568.txt   5256
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Lis William (Reporting) CIK: 0001574558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39138 | Film No.: 231003344

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)